Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intravenous iron in immunosuppressed adults with active IBD-associated anemia
NL-OMON56145Recruiting
- Sponsor
- Litwin-Zucker Center for Alzheimer's Disease and Memory Disorders
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ferrous fumarate and Iron in iron deficiency anemia (IDA) and anemia of inflammation (AI) (2 arms), sponsored by Litwin-Zucker Center for Alzheimer's Disease and Memory Disorders. Started Jun 2022; status: recruiting.
02
Drugs
ferrous fumarateIron
03
Conditions
iron deficiency anemia (IDA)anemia of inflammation (AI)
Beyond the preview
Go deeper on NL-OMON56145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56145.